Publications by authors named "Stuart Turner"

Claim this Profile
E
Experts in traumatic stress are concerned about global impact of what is happening in U.S.
Joan M Cook, Debra L Kaysen, Jackie June Ter Heide, Cherie Armour, Marianne Skogbrott Birkeland, Stuart Turner

Eur J Psychotraumatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Important tool in our rare disease toolbox: hybrid retrospective-prospective natural history studies serve well as external comparators for rare disease studies.
Chinenye Ugoji, Julien Heidt, Joan Largent, Emily Bratton, Laura Hester, Stuart Turner

Front Drug Saf Regul· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An International Longitudinal Natural History Study of Patients With Danon Disease: Unique Cardiac Trajectories Identified Based on Sex and Heart Failure Outcomes.
Kimberly N Hong, Emily Eshraghian, Tarek Khedro, Alessia Argirò, Jennifer Attias, Stuart Turner

J Am Heart Assoc· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dichotomy retreat and aqueous alteration on Noachian Mars recorded in highland remnants.
Joseph D McNeil, Peter Fawdon, Matthew R Balme, Angela L Coe, Javier Cuadros, Stuart M R Turner

Nat Geosci· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fasting vs. no fasting prior to catheterization laboratory procedures: the SCOFF trial.
David Ferreira, Jack Hardy, William Meere, Lloyd Butel-Simoes, Shanathan Sritharan, Stuart Turner

Eur Heart J· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alpelisib plus fulvestrant in PIK3CA-mutated, hormone receptor-positive advanced breast cancer after a CDK4/6 inhibitor (BYLieve): one cohort of a phase 2, multicentre, open-label, non-comparative study.
Hope S Rugo, Florence Lerebours, Eva Ciruelos, Pamela Drullinsky, Manuel Ruiz-Borrego, Nicholas Turner, Stuart Turner

Lancet Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alpelisib for treatment of patients with PIK3CA-related overgrowth spectrum (PROS).
Guillaume Canaud, Juan Carlos Lopez Gutierrez, Alan D Irvine, Pierre Vabres, Jordan R Hansford, Stuart Turner

Genet Med· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
3
30 years on: A brave new world or an unfolding disaster?
Stuart Turner

Torture· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Evaluation of Beta Blocker and ACE-Inhibitor/Angiotensin Receptor Blocker Treatment for Post Infarct Angina in Patients With Myocardial Infarction With Non-obstructive Coronary Arteries: A MINOCA-BAT Sub Study Rationale and Design.
Sivabaskari Pasupathy, Bertil Lindahl, Rosanna Tavella, Anna M Nordenskjöld, Christopher Zeitz, Stuart Turner

Front Cardiovasc Med· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of Alpelisib + Fulvestrant Compared with Real-World Standard Treatment Among Patients with HR+, HER2-, PIK3CA-Mutated Breast Cancer.
Stuart Turner, Stephen Chia, Hemanth Kanakamedala, Wei-Chun Hsu, Jinhee Park

Oncologist· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alpelisib plus fulvestrant in PIK3CA-mutated, hormone receptor-positive advanced breast cancer after a CDK4/6 inhibitor (BYLieve): one cohort of a phase 2, multicentre, open-label, non-comparative study.
Hope S Rugo, Florence Lerebours, Eva Ciruelos, Pamela Drullinsky, Manuel Ruiz-Borrego, Nicholas Turner, Stuart Turner

Lancet Oncol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic treatment of hormone receptor positive, human epidermal growth factor 2 negative metastatic breast cancer: retrospective analysis from Leeds Cancer Centre.
Chris Twelves, Sue Cheeseman, Will Sopwith, Matthew Thompson, Majid Riaz, Stuart Turner

BMC Cancer· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atomic-scale viscoplasticity mechanisms revealed in high ductility metallic glass films.
Hosni Idrissi, Matteo Ghidelli, Armand Béché, Stuart Turner, Sébastien Gravier

Sci Rep· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development, psychometric evaluation, and initial feasibility assessment of a symptom tracker for use by patients with heart failure (HFaST).
Eldrin F Lewis, Theresa M Coles, Sandy Lewis, Lauren M Nelson, Amy Barrett, Stuart J Turner

J Patient Rep Outcomes· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Specificity of Myocardial Perfusion Imaging: Issues With Proposed MBS Item Review.
Michael McGee, David Ferreira, Olav Tvedten, Ehsan Mahmoodi, Nicholas Whitehead, Stuart Turner

Heart Lung Circ· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics of early sacubitril/valsartan patients and considerations for studies in electronic health record data.
Joshua J Gagne, Theodore Tsacogianis, Sara Bruce Wirta, James R Rogers, Frederico Calado, Stuart J Turner

J Comp Eff Res· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanodiamonds as "artificial proteins": Regulation of a cell signalling system using low nanomolar solutions of inorganic nanocrystals.
Lukas Balek, Marcela Buchtova, Michaela Kunova Bosakova, Miroslav Varecha, Silvie Foldynova-Trantirkova, Stuart Turner

Biomaterials· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic evaluation of micafungin versus liposomal amphotericin B (LAmB) for treating patients with candidaemia and invasive candidiasis (IC) in Turkey.
Chin Fen Neoh, Esin Senol, Ates Kara, Ener Cagri Dinleyici, Stuart J Turner

Eur J Clin Microbiol Infect Dis· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Removal of arsenic and mercury species from water by covalent triazine framework encapsulated γ-FeO nanoparticles.
Karen Leus, Karel Folens, Nina Ricci Nicomel, Jeffrey Paulo H Perez, Maria Filippousi, Stuart Turner

J Hazard Mater· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Home-Time After Discharge Among Patients Hospitalized With Heart Failure.
Stephen J Greene, Emily C O'Brien, Robert J Mentz, Nancy Luo, N Chantelle Hardy, Stuart J Turner

J Am Coll Cardiol· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Signs, symptoms, and treatment patterns across serial ambulatory cardiology visits in patients with heart failure: insights from the NCDR PINNACLE® registry.
Larry A Allen, Fengming Tang, Philip Jones, Tracie Breeding, Angelo Ponirakis, Stuart J Turner

BMC Cardiovasc Disord· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness analysis of anidulafungin vs fluconazole for the treatment of invasive candidiasis (IC) in Turkey.
Chin Fen Neoh, Esin Senol, Ates Kara, Ener Cagri Dinleyici, Stuart J Turner

Mycoses· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thiol-ethylene bridged PMO: A high capacity regenerable mercury adsorbent via intrapore mercury thiolate crystal formation.
Dolores Esquivel, Judith Ouwehand, Maria Meledina, Stuart Turner, Gustaaf Van Tendeloo

J Hazard Mater· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Change the management of patients with heart failure: Rationale and design of the CHAMP-HF registry.
Adam D DeVore, Laine Thomas, Nancy M Albert, Javed Butler, Adrian F Hernandez, Stuart J Turner

Am Heart J· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Adoption of Sacubitril/Valsartan for Patients With Heart Failure With Reduced Ejection Fraction: Insights From Get With the Guidelines-Heart Failure (GWTG-HF).
Nancy Luo, Gregg C Fonarow, Steven J Lippmann, Xiaojuan Mi, Paul A Heidenreich, Stuart J Turner

JACC Heart Fail· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis